COMMUNIQUÉS West-GlobeNewswire

Aurora Spine Launches New Biologics Portfolio
27/10/2025
New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV [...]
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
27/10/2025
MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ( Anteris or the Company ) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to [...]
Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration
27/10/2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM), an emerging powerhouse in botanical-based biotechnology, today announced the upcoming launch of its Investor Relations (IR) Presentation [...]
LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics
27/10/2025
Toronto, Ontario, Oct. 27, 2025 (GLOBE NEWSWIRE) -- A childhood cancer diagnosis changes everything for a family. To help provide comfort during this difficult time, LifeLabs has donated customized care packages and [...]
Chiffre d'affaires au 30 septembre 2025
27/10/2025
Communiqué de presse Le chiffre d’affaires du troisième trimestre progresse de +5,1% en base organique En rythme annuel, le chiffre d’affaires au 30 septembre 2025 s’établit à €3 976m, en progression de +4,9% en base [...]
Revenue for the nine months ended 30 September 2025
27/10/2025
Press release Third-quarter organic revenue growth of +5.1% Year to date revenue at 30 September 2025 reached €3,976m, an increase of +4.9% on an organic basis All activities and regions contributed to the momentum in [...]
Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease
27/10/2025
The Alzheimer Society of Ontario calls for immediate system investments to support access to the newly approved dementia treatment TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario applauds the [...]
Fungushead Launches Veteran ‘Angel’s Wing Scholarship’ and Reaffirms Microscopy-Only Standards as California Accelerates Psychedelic Research (AB 1103)
27/10/2025
DENVER, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Fungushead , a microscopy and mycology education company, today announced two key initiatives — the launch of its Angel’s Wing Scholarship for U.S. military veterans and a [...]
Axis Integrated Mental Health Acquires Best Mind to Combat Colorado’s Mental Health Crisis
27/10/2025
Denver-Based Mental Health Leader Expands Services to Reach More Coloradans in Crisis Denver, Colorado, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Axis Integrated Mental Health, recognized as one of the best mental health [...]
Arcutis to Present at Upcoming Investor Conferences
27/10/2025
WESTLAKE VILLAGE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
27/10/2025
Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions World No. 1 and 4-time Grand Slam champion Aryna [...]
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
27/10/2025
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company [...]
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
27/10/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices [...]
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe
27/10/2025
Saint-Herblain (France), le 27 octobre 202 5 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante feront des [...]
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
27/10/2025
Saint- Herblain (France), October 27 , 202 5 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with [...]
Hapbee Appoints New Leaders to Accelerate Women’s Wellness Through Frequency Healing Technology
27/10/2025
Expanding focus into FemTech positions Hapbee to scale across a USD 177 billion market by uniting neuroscience, sleep optimization, and women-led innovation VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE [...]
Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform
27/10/2025
Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies JACKSON CENTER, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) [...]
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
27/10/2025
Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven condition RAPT seeks to develop a differentiated anti-IgE therapy for the many patients [...]
Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer
27/10/2025
SOLANA BEACH, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]

Pages